| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11892-009-0032-7 |
| P698 | PubMed publication ID | 19490820 |
| P50 | author | Ralph A. DeFronzo | Q58689309 |
| P2093 | author name string | Muhammad A Abdul-Ghani | |
| P2860 | cites work | Postchallenge Hyperglycemia and Mortality in a National Sample of U.S. Adults | Q22241282 |
| Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 | ||
| Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 | ||
| Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. | Q46624327 | ||
| Different contributions of insulin resistance and beta-cell dysfunction in overweight Israeli Arabs with IFG and IGT. | Q46723317 | ||
| Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. | Q46786743 | ||
| Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study | Q46850405 | ||
| Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range | Q46901912 | ||
| Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. | Q51551674 | ||
| The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. | Q51554484 | ||
| Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. | Q51560180 | ||
| Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. | Q51561396 | ||
| Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population. | Q51566442 | ||
| The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. | Q51567520 | ||
| Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. | Q51572645 | ||
| Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group | Q66972631 | ||
| Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group | Q77052861 | ||
| Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance | Q77354559 | ||
| Impaired fasting glucose and impaired glucose tolerance: implications for care | Q28290479 | ||
| Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
| Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 | ||
| The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years | Q30577414 | ||
| Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria | Q31931889 | ||
| The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance | Q33705046 | ||
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial | Q33999757 | ||
| Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance | Q34225645 | ||
| Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program | Q34312885 | ||
| Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance | Q34577169 | ||
| Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention | Q34808433 | ||
| The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes | Q35085591 | ||
| Follow-up report on the diagnosis of diabetes mellitus | Q35567871 | ||
| Dysfunctional fat cells, lipotoxicity and type 2 diabetes | Q36202576 | ||
| Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases | Q36408698 | ||
| Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose | Q36462545 | ||
| Is insulin resistance atherogenic? Possible mechanisms | Q36525077 | ||
| Prediabetes and type 2 diabetes in youth: an emerging epidemic disease? | Q37100795 | ||
| Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents | Q37105207 | ||
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
| Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents | Q37311220 | ||
| Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? | Q40819765 | ||
| Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis | Q41491513 | ||
| Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness | Q42435292 | ||
| Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans | Q42498882 | ||
| Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin | Q42525952 | ||
| The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study | Q43540904 | ||
| Disturbances in beta-cell function in impaired fasting glycemia. | Q43869387 | ||
| Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study | Q43959543 | ||
| Comparison of ADA and WHO criteria for the diagnosis of diabetes in elderly Koreans | Q44163423 | ||
| Brazilian individuals with impaired glucose tolerance are characterized by impaired insulin secretion. | Q44274737 | ||
| NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older | Q44418730 | ||
| Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts | Q44453205 | ||
| Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. | Q44545460 | ||
| Lowering the criterion for impaired fasting glucose will not provide clinical benefit | Q44666295 | ||
| Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study | Q44686996 | ||
| Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose | Q44909462 | ||
| Type 2 diabetes mellitus in youth: the complete picture to date | Q44975649 | ||
| Who are more insulin resistant, people with IFG or people with IGT? | Q45009723 | ||
| beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis | Q45105931 | ||
| Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects. | Q46221219 | ||
| Predictors of changes in glucose tolerance status in obese youth | Q46396880 | ||
| P433 | issue | 3 | |
| P921 | main subject | pathophysiology | Q1135939 |
| P304 | page(s) | 193-199 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Current diabetes report | Q26841965 |
| P1476 | title | Pathophysiology of prediabetes | |
| P478 | volume | 9 |
| Q33541007 | A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control |
| Q30824539 | Accurate method to estimate insulin resistance from multiple regression models using data of metabolic syndrome and oral glucose tolerance test |
| Q33749786 | Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes |
| Q36327944 | Advances in the treatment of prediabetes |
| Q46825916 | Association between neonatal hypoglycaemia and prediabetes in postpartum women with a history of gestational diabetes |
| Q39620719 | Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy? |
| Q34505943 | Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis |
| Q34583419 | Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study |
| Q34898643 | Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study |
| Q35858095 | Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline |
| Q57170163 | Diabetes prevalence in rural Indigenous Guatemala: A geographic-randomized cross-sectional analysis of risk |
| Q37214447 | Differences by sex in the prevalence of diabetes mellitus, impaired fasting glycaemia and impaired glucose tolerance in sub-Saharan Africa: a systematic review and meta-analysis |
| Q92840243 | Differential clusters of modifiable risk factors for impaired fasting glucose versus impaired glucose tolerance in adults 50 years of age and older |
| Q42175983 | Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis? |
| Q35696511 | Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance |
| Q54979048 | Early diagnosis of type 2 diabetes based on multiple biomarkers and non-invasive indices. |
| Q42517397 | Early metabolic defects in Arab subjects with strong family history of Type 2 diabetes. |
| Q92857324 | Effect of a family and interdisciplinary intervention to prevent T2D: randomized clinical trial |
| Q39980798 | Elevated serum γ-glutamyltransferase predicts the development of impaired glucose metabolism in middle-aged and elderly Chinese |
| Q43181930 | Evaluation of alpha-glucosidase, alpha-amylase and protein glycation inhibitory activities of edible plants |
| Q36072493 | Exenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-Diabetes |
| Q30276917 | Exercise Intensity Modulates Glucose-Stimulated Insulin Secretion when Adjusted for Adipose, Liver and Skeletal Muscle Insulin Resistance |
| Q30276925 | Exercise resistance across the prediabetes phenotypes: Impact on insulin sensitivity and substrate metabolism |
| Q36124167 | Fasting hyperglycaemia blunts the reversal of impaired glucose tolerance after exercise training in obese older adults. |
| Q64076530 | Forearm bone density is not elevated in Inuit women with impaired fasting glucose or type 2 diabetes mellitus |
| Q47311472 | G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis |
| Q34366110 | GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state |
| Q57787828 | Higher Fasting and Postprandial Free Fatty Acid Levels Are Associated With Higher Muscle Insulin Resistance and Lower Insulin Secretion in Young Non-Obese Women |
| Q35620224 | Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes |
| Q30234363 | Influence of diabetes mellitus on the immunity to human tuberculosis. |
| Q37341971 | Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin-resistant phenotypes. |
| Q42674501 | Know the signs and symptoms of diabetes |
| Q21090997 | MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus |
| Q29035970 | Muscle-specific Pikfyve gene disruption causes glucose intolerance, insulin resistance, adiposity, and hyperinsulinemia but not muscle fiber-type switching |
| Q34299634 | Oral glucose tolerance test-based calculation identifies different glucose intolerance phenotypes within the impaired fasting glucose range |
| Q35913470 | Prediabetes Phenotype Influences Improvements in Glucose Homeostasis with Resistance Training |
| Q30100966 | Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection |
| Q36590348 | Prediabetes: a prevalent and treatable, but often unrecognized, clinical condition |
| Q37507459 | Prevalence and predictors of prediabetes and diabetes among adults in Palau: population-based national STEPS survey |
| Q37203001 | Prevalence of Pre-Diabetes and Its Associated Risk Factors in Rural Areas of Ningbo, China. |
| Q41274592 | Screening and prevention of diabetes |
| Q37882225 | Screening for type 2 diabetes and dysglycemia |
| Q34408165 | Sleep apnea predicts distinct alterations in glucose homeostasis and biomarkers in obese adults with normal and impaired glucose metabolism |
| Q34131002 | Strong association between insulin-mediated glucose uptake and the 2-hour, not the fasting plasma glucose concentration, in the normal glucose tolerance range |
| Q34883950 | The association between self-reported lack of sleep, low vitality and impaired glucose tolerance: a Swedish cross-sectional study. |
| Q35067257 | The prediabetic period: review of clinical aspects |
| Q38049606 | The proposed GDM diagnostic criteria: a difference, to be a difference, must make a difference |
| Q34718244 | The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study. |
| Q26783350 | Treatment of prediabetes |
| Q37005875 | Unexpected severe consequences of Pikfyve deletion by aP2- or Aq-promoter-driven Cre expression for glucose homeostasis and mammary gland development |
| Q34277840 | Uric acid is more strongly associated with impaired glucose regulation in women than in men from the general population: the KORA F4-Study |
| Q37946372 | What we have learnt about PIKE from the knockout mice |
| Q21136353 | alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population |
Search more.